Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 – 2019 outbreak

References

• Goodson JL, Seward JF. Measles 50 years after use of measles vaccine. Infect Dis Clin North Am. 2015;29:725–43. doi:10.1016/j.idc.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Measles. In: Hamborsky J, Kroger A, Wolfe S, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th. Washington (DC): Public Health Foundation; 2015. 209–30. Accessed 2020 May 5. http://www.cdc.gov/vaccines/pubs/pinkbook/index.html
   Google Scholar
• Israel Center for Diseases Control (ICDC) and division of epidemiology, public health services. Notifiable infectious diseases in Israel: 60 years of surveillance 1951–2010. 2012.
   Google Scholar
• World Health Organization Regional Office for Europe (WHO/Europe). 4th Meeting of the European Regional Verification Commission for Measles and Rubella Elimination, Copenhagen. 2016. [Accessed 2020 May 05]. http://www.euro.who.int/__data/assets/pdf_file/0011/304958/4th-RVC-meeting-report.pdf
   Google Scholar
• World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2018 global summary. 2019. [Accessed 2020 May 05]. https://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=ISR
   Google Scholar
• Avramovich E, Indenbaum V, Haber M, Amitai Z, Tsifanski E, Farjun S, Sarig A, Bracha A, Castillo K, Markovich MP, et al. Measles outbreak in a highly vaccinated population - Israel, July-August 2017. MMWR Morb Mortal Wkly Rep. 2018;67:1186–88. doi:10.15585/mmwr.mm6742a4.
   PubMed Web of Science ®Google Scholar
• Kopel E, Amitai Z, Savion M, Aboudy Y, Mendelson E, Sheffer R. Ongoing African measles virus genotype outbreak in Tel Aviv district since April, Israel, 2012. Euro Surveill. 2012;17:20272.
   PubMedGoogle Scholar
• World Health Organization. Measles in Europe: record number of both sick and immunized. 2019. [Accessed 2020 May 05]. http://www.euro.who.int/en/media-centre/sections/press-releases/2019/measles-in-europe-record-number-of-both-sick-and-immunized
   Google Scholar
• Fraser B. Measles outbreak in the Americas. Lancet. 2018;392:373. doi:10.1016/S0140-6736(18)31727-6.
   PubMed Web of Science ®Google Scholar
• Al-Abdullah N. A measles outbreak in a refugee community in Jeddah City, Saudi Arabia. J Hosp Infect. 2018;100:e264–e265. doi:10.1016/j.jhin.2018.05.018.
   PubMed Web of Science ®Google Scholar
• Georgakopoulou T, Horefti E, Vernardaki A, Pogka V, Gkolfinopoulou K, Triantafyllou E, Tsiodras S, Theodoridou M, Mentis A, Panagiotopoulos T. Ongoing measles outbreak in Greece related to the recent European-wide epidemic. Epidemiol Infect. 2018;146:1692–98. doi:10.1017/S0950268818002170.
   PubMed Web of Science ®Google Scholar
• Osborne K, Weinberg J, Miller E. The European sero-epidemiology network. Eurosurveillance. 1997;2:29–31. doi:10.2807/esm.02.04.00167-en.
   Google Scholar
• Cohen BJ, Audet S, Andrews N, Beeler J. WHO working group on measles plaque reduction neutralization test. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine. 2007;26:59–66. doi:10.1016/j.vaccine.2007.10.046.
   PubMed Web of Science ®Google Scholar
• Forsey T, Heath AB, Minor PD. The 1st international standard for anti-measles serum. Biologicals. 1991;19:237–41. doi:10.1016/1045-1056(91)90042-I.
   PubMed Web of Science ®Google Scholar
• Bester JC. Measles and measles vaccination: a review. JAMA Pediatr. 2016;170:1209–15. doi:10.1001/jamapediatrics.2016.1787.
   PubMed Web of Science ®Google Scholar
• Hahné SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, van Binnendijk RS. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016;214:1980–86. doi:10.1093/infdis/jiw480.
   PubMed Web of Science ®Google Scholar
• Trentini F, Poletti P, Melegaro A, Merler S. The introduction of ‘No jab, No school’ policy and the refinement of measles immunisation strategies in high-income countries. BMC Med. 2019;17:86. doi:10.1186/s12916-019-1318-5.
   PubMed Web of Science ®Google Scholar
• Trentini F, Poletti P, Merler S, Melegaro A. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017;17:1089–97. doi:10.1016/S1473-3099(17)30421-8.
   PubMed Web of Science ®Google Scholar
• Emek M, Islek D, Atasoylu G, Ozbek OA, Ceylan A, Acikgoz A, Tay Z, Demiral Y, Oktem MA, Unal B. Association between seroprevalence of measles and various social determinants in the year following a measles outbreak in Turkey. Public Health. 2017;147:51–58. doi:10.1016/j.puhe.2017.01.026.
   PubMed Web of Science ®Google Scholar
• Pei L, Yang Y, Zhao X, Zhang S, Yuan L, Liu Y, Yu Y. Identify the susceptibility profile to measles in the general population: serological survey of measles antibodies in Shaanxi province, China, in 2016. Vaccine. 2017;35:7250–55. doi:10.1016/j.vaccine.2017.11.012.
   PubMed Web of Science ®Google Scholar
• Gidding HF, Quinn HE, Hueston L, Dwyer DE, McIntyre PB. Declining measles antibodies in the era of elimination: Australia’s experience. Vaccine. 2018;36:507–13. doi:10.1016/j.vaccine.2017.12.002.
   PubMed Web of Science ®Google Scholar
• Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, Wallace GS, McLean HQ. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010. Open Forum Infect Dis. 2015;2:ofv006. doi:10.1093/ofid/ofv006.
   PubMed Web of Science ®Google Scholar
• Tomášková H, Zelená H, Kloudová A, Tomášek I. Serological survey of measles immunity in the Czech Republic, 2013. Cent Eur J Public Health. 2018;26:22–27. doi:10.21101/cejph.a5251.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Wang D, Lin W, Tang H, Chen S, Ni J. Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China. Hum Vaccin Immunother. 2014;10:1097–2003. doi:10.4161/hv.27734.
   PubMed Web of Science ®Google Scholar
• Mollema L, Smits GP, Berbers GA, Van Der Klis FR, Van Binnendijk RS, De Melker HE, Hahné SJ. High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands. Epidemiol Infect. 2014;142:1100–08. doi:10.1017/S0950268813001532.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Vaccine for Measles. 2019. [Accessed 2020 May 05]. https://www.cdc.gov/measles/vaccination.html
   Google Scholar
• Kang HJ, Han YW, Kim SJ, Kim YJ, Kim AR, Kim JA, Jung HD, Eom HE, Park O, Kim SS. An increasing, potentially measles-susceptible population over time after vaccination in Korea. Vaccine. 2017;35:4126–32.
   PubMed Web of Science ®Google Scholar
• Division of epidemiology, public health services, Israel Ministry of Health
   Google Scholar
• Stein-Zamir C, Shoob H, Abramson N, Zentner G. Who are the children at risk? Lessons learned from measles outbreaks. Epidemiol Infect. 2012;140:1578–88.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Sabbe M, Van Damme P. Measles outbreak in Europe: susceptibility of infants too young to be immunized. Vaccine. 2012;30:5905–13. doi:10.1016/j.vaccine.2012.07.035.
   PubMed Web of Science ®Google Scholar
• Sindhu TG, Geeta MG, Krishnakumar P, Sabitha S, Ajina KK. Clinical profile of measles in children with special reference to infants. Trop Doct. 2019;49:20–23. doi:10.1177/0049475518804695.
   PubMed Web of Science ®Google Scholar
• Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA. 1998;280:527–32. doi:10.1001/jama.280.6.527.
   PubMed Web of Science ®Google Scholar
• Carazo Perez S, De Serres G, Bureau A, Skowronski DM. Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose. Clin Infect Dis. 2017;65:1094–102. doi:10.1093/cid/cix510.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Lee PI, Hsieh YC, Chen PY, Ho YH, Chang CJ, Liu DP, Chang FY, Chiu CH, Huang YC, et al. Waning population immunity to measles in Taiwan. Vaccine. 2012;30:6721–27. doi:10.1016/j.vaccine.2012.05.019.
   PubMed Web of Science ®Google Scholar
• Ratnam S, Gadag V, West R, Burris J, Oates E, Stead F, Bouilianne N. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol. 1995;33:811–15. doi:10.1128/JCM.33.4.811-815.1995.
   PubMed Web of Science ®Google Scholar
• Hogg GG, Darlington RJ, Hogg KG, Lester R. Measles immunity and immunisation status in Australian children 1 to 4 years of age. J Paediatr Child Health. 2006;42:165–69. doi:10.1111/j.1440-1754.2006.00823.x.
   PubMed Web of Science ®Google Scholar
• Dorigo-Zetsma JW, Leverstein-van Hall MA, Vreeswijk J, de Vries JJ, Vossen AC, Ten Hulscher HI, Kerkhof J, Smits GP, Ruijs WL, Koopmans MP, et al. Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs. J Clin Virol. 2015;69:214–18. doi:10.1016/j.jcv.2015.06.095.
   PubMed Web of Science ®Google Scholar
• Wallinga J, Heijne JC, Kretzschmar M. A measles epidemic threshold in a highly vaccinated population. PLoS Med. 2005;2:e316. doi:10.1371/journal.pmed.0020316.
   PubMed Web of Science ®Google Scholar